DeepMed Research

NATIONAL UNIVERSITY HOSPITAL (SINGAPORE) PTE LTD

🇸🇬Singapore

Country: 🇸🇬Singapore

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Pyruvate Kinase Isoform M2 (PKM2) as a Possible Biomarker for Cancer

Completed

Conditions: Cancer

Interventions: Other: Pyruvate kinase isoform M2

First Posted Date: 2010-05-26

Last Posted Date: 2013-12-11

Lead Sponsor: National University Hospital, Singapore

Registration Number: NCT01130584

Locations: 🇸🇬
National University Hospital, Singapore, Singapore, Singapore

Polycaprolactone / Tricalcium Phosphate (PCL/TCP) v Titanium Orbital Implant : Randomised Trial

Phase 2

Conditions: Fractures
Enophthalmos
Diplopia

Interventions: Device: Polycaprolactone / Tri-Calcium Phosphate
Device: Titanium Mesh

First Posted Date: 2010-05-07

Last Posted Date: 2014-04-28

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 80

Registration Number: NCT01119144

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

Expression of S100A2 and Trefoil Factor Family Members in Epstein-Barr Virus Related Gastric Cancer

Conditions: Gastric Cancer

First Posted Date: 2010-04-09

Last Posted Date: 2014-01-22

Lead Sponsor: National University Hospital, Singapore

Registration Number: NCT01100814

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status

Conditions: NSCLC

Interventions: Other: EGFR mutation status in patients

First Posted Date: 2010-04-09

Last Posted Date: 2013-12-11

Lead Sponsor: National University Hospital, Singapore

Registration Number: NCT01100827

Locations: 🇸🇬
National University Hospital Singapore, Singapore, Singapore

A Retrospective Study of Biomarkers in Non-Small Cell Lung Cancer

Conditions: Non Small Cell Lung Cancer

First Posted Date: 2010-04-09

Last Posted Date: 2013-12-11

Lead Sponsor: National University Hospital, Singapore

Registration Number: NCT01100840

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients

Phase 2

Conditions: Recurrent Gastric Cancer

Interventions: Drug: TS-1 with cisplatin
Drug: TS-1 with oxaliplatin

First Posted Date: 2010-04-09

Last Posted Date: 2016-06-22

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 90

Registration Number: NCT01100801

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma

Phase 2

Terminated

Conditions: Carcinoma
Therapy

First Posted Date: 2010-04-01

Last Posted Date: 2014-01-14

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 20

Registration Number: NCT01097083

Locations: 🇸🇬
National Cancer Centre, Singapore, Singapore
🇸🇬
Singapore General Hospital, Singapore, Singapore
🇸🇬
National University Hospital, Singapore, Singapore

A Study of TS-1, Cisplatin (CDDP) and RAD001 (Everolimus)

Phase 1

Terminated

Conditions: Cancer

First Posted Date: 2010-03-31

Last Posted Date: 2014-01-22

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 35

Registration Number: NCT01096199

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

Metabolic Effects of Birth Weight on Overweight and Obese Chinese Adults and Their Responses to Weight Loss

Not Applicable

Conditions: Healthy
Overweight
Obesity

Interventions: Procedure: Dietary and Exercise Intervention

First Posted Date: 2010-03-04

Last Posted Date: 2010-03-04

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 180

Registration Number: NCT01080378

Locations: 🇸🇬
SGH Life Centre, Singapore, Singapore
🇸🇬
National University Hospital, Singapore, Singapore

The Chloroquine for Influenza Prevention Trial

Phase 2

Conditions: Influenza

Interventions: Drug: Placebo
Drug: Chloroquine

First Posted Date: 2010-03-02

Last Posted Date: 2010-03-02

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 1516

Registration Number: NCT01078779

Locations: 🇸🇬
Investigational Medicines Unit, National University Hospital, Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy